Riskpilot← Back to searchSign inGet full accessMONALISA KLINIKKEN AS
ASActiveOrg 921221649Schweigaards Gate 63, 0656 OsloBeauty care and other beauty treatment activities · NACE 9622Est. 20180 employees
Revenue 2024
NOK 0
EBITDA margin
—
+94% vs 2023
Equity ratio
-224.5%
Financial strength
Net profit 2024
NOK -11K
+94% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -11K | +94% |
| Net profit | NOK -11K | +94% |
| Total assets | NOK 47K | -11% |
| Equity | NOK -106K | -11% |
| Employees | 0 | — |
Legal name
MONALISA KLINIKKEN AS
Org number
921221649
Legal form
Aksjeselskap
NACE code
9622 · Beauty care and other beauty treatment activities
Founded
7. august 2018
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Helsetjenester i form av enkelte medisinske konsultasjoner, medisinsk og kosmetisk behandling med botulinum toxin. Kosmetisk og estetisk-medisinsk behandling. Sertifisering, kurs og opplæring, salg av kosmetiske produkter samt laserbehandling for fjerning av hår og andre hudpleie behandlinger som naturlig står i den forbindelse.
Address
Schweigaards Gate 63, 0656 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 582 | 1 619 | 910 | 530 | 0 |
| Staff expenses | −0 | −87 | −392 | −0 | −0 |
| EBITDA | −4 | 386 | −163 | −173 | −11 |
| Depreciation & amort. | −42 | −58 | −44 | −14 | −0 |
| EBIT | −46 | 329 | −207 | −188 | −11 |
| Net financials | −7 | 1 | −3 | −3 | −0 |
| Profit before tax | −53 | 329 | −211 | −191 | −11 |
| Tax | 0 | 70 | −0 | −0 | −0 |
| Net profit | −53 | 259 | −211 | −191 | −11 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 762 | 466 | 217 | 53 | 47 |
| Equity | 33 | 292 | 96 | −95 | −106 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 729 | 174 | 120 | 148 | 153 |
| Total debt | 729 | 174 | 120 | 148 | 153 |
EBITDA margin
-1062400.0%
This company
15.8%
Market median
-6724151% vs market
20202024
Equity ratio
-224.5%
This company
38.2%
Market median
-688% vs market
20202024
Return on equity
-1062500.0%
This company
18.4%
Market median
-5774557% vs market
20202024
Net profit margin
-1062500.0%
This company
8.1%
Market median
-13117384% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
1.45×
This company
0.62×
Market median
-134% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AK Chief Executive Officer | Chief Executive Officer | 2020 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MONALISA KLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ardavan Karimi | Chief Executive Officer | 0 companies |